Henri Termeer Overview

  • Investor Type
  • Angel

  • Status
  • Active

  • Professionals
  • 1


  • Investments
  • 10

  • Portfolio
  • 2

  • Exits
  • 5


Henri Termeer General Information


Mr. Henri Termeer is a Co-Founder of Arrakis Therapeutics. He serves as a Board Member at Aura Biosciences. He serves as Lead Director at Verastem. He also serves as Chief Executive Officer at Deknatel-Snowden Pencer. He served as the Board Member at Medical Simulation. Before June 2011, he had served as president and a director of Genzyme Corporation, a leading global public biotechnology company, since October 1983, as chief executive officer since 1985, and as chairman of the board since May 1988. He was co-chairman of the transition committee following the acquisition of Genzyme by Sanofi in April 2011 and resigned from Genzyme in June 2011 following the completion of the initial phase of the integration plan. He is also chairman emeritus of the New England Healthcare Institute, a nonprofit, applied research health policy organization that he was instrumental in founding. He served as a director of Allergan from 2014 to 2015 and a director of the Pharmaceutical Research and Manufacturers of America from 1997 to 2011. He is also a former chairman of the Federal Reserve Bank of Boston's board of directors and served as a board member of ABIOMED Inc., a public medical device company; Moderna Therapeutics, a private biotechnology company; and ProQR Therapeutics, a Netherlands-based biotechnology company focused on the development of drugs to treat genetic disorders. He is a Board Member of the Massachusetts Institute of Technology Corporation and serves on its executive committee. He is a Director of Massachusetts General Hospital, a board member of Partners HealthCare, and a member of the board of fellows of Harvard Medical School.

Business Details

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Corporate Office
  • United States

Henri Termeer Investments (10)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Arrakis Therapeutics 10-Apr-2019 Early Stage VC 0000 Drug Discovery Product Development 00000 0000000
Aura Biosciences 13-Dec-2018 00000 00000 000.00 Drug Discovery Generating Revenue/Not Profitable 00000 0000000
Arrakis Therapeutics 02-Mar-2017 00000 00000 000.00 Drug Discovery Product Development 00000 0000000
Amylyx 22-Aug-2016 00000 00000 000 Drug Discovery Profitable 00000 0000000
Twine Health 07-Dec-2015 00000 00000 00.000 Other Healthcare Technology Systems Generating Revenue 00000 0000000
Artax Biopharma 22-Sep-2015 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 00000 0000000
X4 Pharmaceuticals 28-Aug-2015 00000 00000 000.00 Biotechnology Profitable 00000 0000000
Aura Biosciences 05-Mar-2015 00000 00000 0000 Drug Discovery Generating Revenue/Not Profitable 00000 0000000
Arrakis Therapeutics 01-Jan-2015 Seed Round 000 Drug Discovery Product Development 00000 0000000
NanoString Technologies 07-Nov-2011 Later Stage VC 000.00 Biotechnology Generating Revenue/Not Profitable 00000 0000000

Henri Termeer Exits (5)

Company Name Exit Date Exit Type Exit Size
Amylyx 07-Jan-2022 IPO 00000
Aura Biosciences 02-Nov-2021 000 000.00
Twine Health 01-Feb-2018 000000000000000000 000.00
NanoString Technologies 26-Jun-2013 IPO 0000
X4 Pharmaceuticals Secondary Transaction - Open Market

Henri Termeer Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Henri Termeer Team (1)

Name Title Deals Funds Boards Office
Henri Termeer Angel Investor 00 0

Henri Termeer FAQs

  • Who is Henri Termeer?

    Henri Termeer is an angel Investor who has made 10 investments.

  • What kind of investor is Henri Termeer?

    Henri Termeer is an angel investor.

  • What does Henri Termeer do?

    As an angel investor, Henri Termeer invests personal money into promising companies, typically in exchange for equity.

  • How many board seats does Henri Termeer hold?

    Henri Termeer holds 2 board seats including Aura Biosciences and Medical Simulation.

  • What has Henri Termeer invested in?

    Henri Termeer has made numerous investments in companies like Arrakis Therapeutics, Aura Biosciences, and Amylyx within the Drug Discovery industry.

  • What has Henri Termeer invested in recently?

    Henri Termeer's latest investment was on 10-Apr-2019 in Arrakis Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »